Eli Lilly and (LLY)
NYSE: LLY
· Real-Time Price · USD
722.89
-1.65 (-0.23%)
At close: Sep 29, 2025, 1:22 PM
Oncology Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 2.41B | 466.1M | +23.93% |
| Mar 31, 2025 | 1.95B | -608.6M | -23.81% |
| Sep 30, 2024 | 2.56B | 98.3M | +4.00% |
| Jun 30, 2024 | 2.46B | 2.22B | +916.04% |
| Mar 31, 2024 | 241.9M | -34.2M | -12.39% |
| Sep 30, 2023 | 276.1M | -38.5M | -12.24% |
| Jun 30, 2023 | 314.6M | 39.3M | +14.28% |
| Mar 31, 2023 | 275.3M | -470.7M | -63.10% |
| Sep 30, 2022 | 746M | 251.3M | +50.80% |
| Jun 30, 2022 | 494.7M | -1.43B | -74.27% |
| Mar 31, 2022 | 1.92B | 1.29B | +201.55% |
| Sep 30, 2021 | 637.7M | -75.2M | -10.55% |
| Jun 30, 2021 | 712.9M | -530M | -42.64% |
| Mar 31, 2021 | 1.24B | 716.5M | +136.11% |
| Sep 30, 2020 | 526.4M | 45.4M | +9.44% |
| Jun 30, 2020 | 481M | -159.1M | -24.86% |
| Mar 31, 2020 | 640.1M | 336.6M | +110.91% |
| Sep 30, 2019 | 303.5M | -20M | -6.18% |
| Jun 30, 2019 | 323.5M | -98.1M | -23.27% |
| Mar 31, 2019 | 421.6M | n/a | n/a |
| Dec 31, 2015 | n/a | n/a | n/a |
| Sep 30, 2015 | n/a | n/a | n/a |
| Jun 30, 2015 | n/a | n/a | n/a |
| Mar 31, 2015 | n/a | n/a | n/a |
| Dec 31, 2014 | n/a | n/a | n/a |
| Sep 30, 2014 | n/a | n/a | n/a |
| Jun 30, 2014 | n/a | n/a | n/a |
| Mar 31, 2014 | n/a | n/a | n/a |
| Dec 31, 2013 | n/a | n/a | n/a |
| Sep 30, 2013 | n/a | n/a | n/a |
| Jun 30, 2013 | n/a | n/a | n/a |
| Mar 31, 2013 | n/a | n/a | n/a |
| Dec 31, 2012 | n/a | n/a | n/a |
| Sep 30, 2012 | n/a | n/a | n/a |
| Jun 30, 2012 | n/a | n/a | n/a |
| Mar 31, 2012 | n/a | n/a | n/a |
| Sep 30, 2011 | n/a | n/a | n/a |
| Jun 30, 2011 | n/a | n/a | n/a |
| Mar 31, 2011 | n/a | n/a | n/a |
| Sep 30, 2010 | n/a | n/a | n/a |